We are live on ! Find out more
VCNX

Vaccinex, Inc. Common Stock
VCNX

Delisted

VCNX was delisted on the 17th of December, 2024.

Back to rankings

12 hedge funds and large institutions have $5.69M invested in Vaccinex, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more funds holding

Funds holding: 11 → 12 (+1)

21% less capital invested

Capital invested by funds: $7.21M → $5.69M (-$1.52M)

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$60.1K
2
BlackRock
BlackRock
New York
+$12.5K
3
Victory Capital Management
Victory Capital Management
Texas
+$11.3K

Top Sellers

Rank Fund Capital Flow
1
MP
MSD Partners
New York
-$343K
2
Millennium Management
Millennium Management
New York
-$64.6K
3
UBS Group
UBS Group
Switzerland
-$9.07K
4
OC
Oppenheimer & Co
New York
-$7.93K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$3.4K

VCNX Hedge Fund Activity: Q1 2020 in Review

12 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q1 2020, worth a combined $5.69M — down 21% from $7.21M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new VCNX positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 5 trimmed.

The largest buyer was Vanguard Group, adding an estimated $60.1K. The largest seller was MSD Partners, cutting an estimated $343K.

  • 12 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q1 2020, up from 11 in Q4 2019.
  • Funds reported $5.69M of Vaccinex, Inc. Common Stock stock for Q1 2020, down 21% quarter-over-quarter.
  • 2 funds opened new Vaccinex, Inc. Common Stock positions in Q1 2020 and 0 closed out, a net change of +2 holders.
  • The largest Vaccinex, Inc. Common Stock buyer in Q1 2020 was Vanguard Group, an estimated $60.1K added.
  • The largest Vaccinex, Inc. Common Stock seller in Q1 2020 was MSD Partners, an estimated $343K sold.

Based on aggregated 13F filings for Q1 2020.